Anavex Life Sciences Corp...

NASDAQ: AVXL · Real-Time Price · USD
9.91
-0.20 (-1.98%)
At close: Aug 15, 2025, 3:59 PM
10.26
3.48%
After-hours: Aug 15, 2025, 06:30 PM EDT

Anavex Life Sciences Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
PE Ratio
-11.03 -11 -16.54 -33.05
PEG Ratio
0.83 3.41 -1.12 -1.65
PS Ratio
n/a n/a n/a n/a
PB Ratio
3.94 3.68 5.57 8.31
P/FCF Ratio
-15.39 -18.81 -32.75 -41.24
P/OCF Ratio
-15.39 -18.81 -32.75 -41.24
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a n/a
Quick Ratio
8.86 12.32 14.95 14.97
Current Ratio
8.86 12.32 14.95 14.97
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a -57.84 -53.84 n/a
Return on Equity
-0.36 -0.33 -0.34 -0.25
Return on Assets
-0.32 -0.31 -0.31 -0.23
Return on Invested Capital
-0.42 -0.38 -0.01 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a